NASDAQ:ONCY

Oncolytics Biotech Stock Insider Trading

etoro logo Buy ONCY
*Your capital is at risk
$0.88
-0.0476 (-5.13%)
At Close: Jun 03, 2026

Oncolytics Biotech Stock Insider Power

Based on the 87 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 10.39M and sold 0 ONCY shares in the last 87 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 87 transactions)
100.00
Buy 10.39M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jan 01, 2026
Buy
Stock Option
Andrews Patricia S
Director
Director 30 000
Value: $32.4K
Jan 01, 2026
Buy
Stock Option
Andrews Patricia S
Director
Director 45 000
Value: $79.2K
Jan 01, 2026
Buy
Common Shares
Andrews Patricia S
Director
Director 0
Value: $0
Jan 01, 2026
Buy
Stock Option
Look Kirk
Chief Financial Officer
C-Suite Officer 250 000
Value: $247.5K
Jan 01, 2026
Buy
Stock Option
Look Kirk
Chief Financial Officer
C-Suite Officer 570 000
Value: $615.6K
Jan 01, 2026
Buy
Stock Option
Look Kirk
Chief Financial Officer
C-Suite Officer 243 600
Value: $275.3K
Jan 01, 2026
Buy
Stock Option
Look Kirk
Chief Financial Officer
C-Suite Officer 231 700
Value: $442.5K
Jan 01, 2026
Buy
Stock Option
Look Kirk
Chief Financial Officer
C-Suite Officer 105 000
Value: $289.8K
Jan 01, 2026
Buy
Stock Option
Look Kirk
Chief Financial Officer
C-Suite Officer 80 000
Value: $184.8K
Jan 01, 2026
Buy
Stock Option
Look Kirk
Chief Financial Officer
C-Suite Officer 155 000
Value: $527.0K
Jan 01, 2026
Buy
Stock Option
Look Kirk
Chief Financial Officer
C-Suite Officer 31 578
Value: $84.0K
Jan 01, 2026
Buy
Stock Option
Parsons James T.
Director
Director 30 000
Value: $33.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ONCOLYTICS BIOTECH INC.
Oncolytics Biotech
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE